WWP2 and ischemic cardiomyopathy: In in vivo studies using hypertension-induced non-ischemic cardiomyopathy (NICM) mouse models, WWP2 deficiency has reduced cardiac fibrosis and ameliorated disease progression, suggesting that WWP2-mediated IRF7 ubiquitination is a key driver of fibrosis in NICM [46].